Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
6.
J Eukaryot Microbiol ; 47(6): 581-4, 2000.
Article in English | MEDLINE | ID: mdl-11128711

ABSTRACT

A cDNA clone derived from Pneumocystis carinii contained an unusual sequence (GTGATG)2(ATGGTG)4(ATG)4 and many GAT repeats. It was found to encode a histidine and aspartic acid-rich protein (HARP). The complete cDNA contained an 888-bp open reading frame encoding a putative protein of 32.6 kDa. The deduced HARP protein contained 39 aspartic acid and 22 histidine residues. The genomic copy of the HARP gene (1203 bp in length) was found to contain 3 small introns of 46, 44, and 38 bp, respectively. HARP was predicted by computer programs to be a plasma membrane protein with nickel-binding activity.


Subject(s)
Fungal Proteins/chemistry , Fungal Proteins/genetics , Genes, Fungal , Membrane Proteins/chemistry , Membrane Proteins/genetics , Pneumocystis/genetics , Amino Acid Motifs , Amino Acid Sequence , Aspartic Acid/analysis , Base Sequence , Cloning, Molecular , DNA, Complementary , DNA, Fungal/chemistry , DNA, Fungal/genetics , Electrophoresis, Gel, Pulsed-Field , Fungal Proteins/metabolism , Histidine/analysis , Membrane Proteins/metabolism , Molecular Sequence Data , Molecular Weight , Nickel/metabolism , Open Reading Frames , Pneumocystis/chemistry , Polymerase Chain Reaction , Protein Structure, Tertiary , Repetitive Sequences, Nucleic Acid , Sequence Homology, Amino Acid , Software
10.
Infect Immun ; 67(2): 805-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9916094

ABSTRACT

To evaluate the feasibility of mucosal immunization against Pneumocystis carinii (Pc) experimental infection, female BALB/c mice were intranasally immunized three times with soluble Pc antigens plus cholera toxin fraction B (Pc-CTB); control groups received either Pc antigen, CTB, or phosphate-buffered saline (PBS) alone. Two weeks after the last immunization, five animals from each group were sacrificed, and cellular and humoral immune responses were evaluated. The remaining five mice were CD4 depleted using a monoclonal antibody against mouse CD4 and inoculated with viable Pc. Significantly higher specific lymphoproliferative responses from tracheobronchial lymph node cells, immunoglobulin M (IgM) and IgG antibody levels in serum, and bronchoalveolar lavage (BAL)-derived IgA antibody concentrations were observed in the Pc-CTB group of mice relative to control groups (P < 0.01). Five weeks after challenge, no Pc organisms were observed in the lung smears of the Pc-CTB group, while the animals receiving antigen, adjuvant, or PBS had progressively higher numbers of Pc microorganisms. By Western blot analysis, a strongly reactive 55- to 60-kDa antigen was recognized by BAL IgA and by serum IgG. In summary, mucosal immunization elicited specific cellular and humoral immune responses and protected against Pc lung infection after immunosuppression.


Subject(s)
Fungal Vaccines/immunology , Pneumocystis/immunology , Pneumonia, Pneumocystis/prevention & control , Administration, Intranasal , Animals , Antibodies, Bacterial/immunology , Blotting, Western , Bronchoalveolar Lavage , CD4-Positive T-Lymphocytes/immunology , Disease Models, Animal , Electrophoresis, Polyacrylamide Gel , Feasibility Studies , Female , Fungal Vaccines/administration & dosage , Lymphocyte Depletion , Mice , Mice, Inbred BALB C , Pneumonia, Pneumocystis/immunology , Sodium Dodecyl Sulfate , Vaccination
11.
Clin Diagn Lab Immunol ; 5(1): 74-7, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9455884

ABSTRACT

Well-proven mouse and rat models were used to show that polyclonal antisera to Pneumocystis carinii protect against P. carinii pneumonia. Antibodies were obtained from animals that were allowed to recover from severe P. carinii pneumonia after immunosuppression had been stopped and which then were given a booster injection of P. carinii from the same animal species. Mice immunosuppressed with corticosteroids or antibodies to L3T4+ lymphocytes (which are comparable to CD4 cells of humans) and transtracheally inoculated with mouse P. carinii did not develop P. carinii pneumonia if they were passively immunized with antiserum, while mice immunosuppressed and inoculated by identical procedures but not given antibodies developed severe infections. Rats immunosuppressed with corticosteroids and inoculated with rat P. carinii had less severe infections if they were given rat anti-P. carinii antisera. The polyclonal antisera developed in mice provided greater protection for the mice than the polyclonal rat antisera did for the rats; however, the potencies and compositions of the antisera were not quantitated and probably differed. Since both rats and mice can be protected from P. carinii infections with polyclonal antisera, it may be possible to develop vaccines that will elicit protective antibodies in humans.


Subject(s)
Antibodies, Protozoan/therapeutic use , Immunotherapy , Pneumocystis/immunology , Pneumonia, Pneumocystis/prevention & control , Animals , Anti-Inflammatory Agents/pharmacology , Antigens, Differentiation, T-Lymphocyte/immunology , Dexamethasone/pharmacology , Immune Tolerance/drug effects , Membrane Glycoproteins/blood , Membrane Glycoproteins/immunology , Mice , Mice, Inbred BALB C , Rats , Rats, Sprague-Dawley
12.
J Clin Microbiol ; 35(10): 2511-3, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9316898

ABSTRACT

The means by which humans acquire Pneumocystis carinii is not well understood. Whether it can be acquired from specific environmental sources or transmitted from person to person has not been determined. This study was designed to detect nucleic acids of P. carinii in air samples from various locations, including P. carinii-infected patients' homes and hospital rooms, non-P. carinii-infected patients' hospital rooms, empty hospital rooms, offices at Indiana University, and other homes in different locations. DNA was extracted from cellulose-ester filters through which air samples had been filtered, and the P. carinii DNA was amplified by PCR with primers specific for the internal transcribed spacer regions of rRNA. P. carinii DNA was found in 17 of 30 air samples (57%) from the rooms of P. carinii-infected patients. It was also found in 6 of the 21 other hospital rooms sampled (29%) but was not found in any of the offices, storage areas, or control homes. Environmental sampling suggests that the airborne presence of P. carinii genetic material and infectious organisms is plausible. The organism was also detected in locations where P. carinii patients were not immediately proximate, such as the hospital rooms of non-P. carinii-infected patients.


Subject(s)
Air Microbiology , DNA, Bacterial/isolation & purification , Pneumocystis Infections/transmission , Pneumocystis/isolation & purification , DNA, Bacterial/genetics , DNA, Ribosomal/genetics , Disease Susceptibility , HIV Infections , Hospitals , Housing , Humans , Lung/microbiology , Pneumocystis/genetics , Risk Assessment
17.
Biochem J ; 316 ( Pt 2): 681-4, 1996 Jun 01.
Article in English | MEDLINE | ID: mdl-8687417

ABSTRACT

Pneumocystis carinii is an opportunistic fungus which causes interstitial pneumonia in patients with acquired immunodeficiency syndrome (AIDS). Cytoplasmic pH (pHi) regulation in short-term-cultured P. carinii trophozoites was studied using the fluorescent dye 2',7'-bis-(2-carboxyethyl)-5-(-6)-carboxyfluorescein. With an extracellular pH of 7.4, the mean baseline pHi of P. carinii trophozoites was 7.40 +/- 0.10 (n = 8). This steady-state pHi was not significantly affected in the absence of extracellular Na+ or K+. Moreover, steady-state pHi was maintained in the nominal absence of HCO3- and was not affected by the Cl-/HCO(3-)-exchanger inhibitor 4, 4'-di-isothiocyanato-dihydrostilbene-2, 2'-disulphonic acid (100 microM), or the Na+/H(+)-exchanger inhibitor N-ethyl-N-isopropylamiloride (100 microM). In contrast, the general inhibitors of ATPases, N-ethylmaleimide (1 mM), and dicyclohexylcarbodi-imide (100 microM), and the inhibitor of yeast H(+)-ATPase, diethylstilbestrol (12.5-100 microM), decreased pHi, while the K+/H(+)-ATPase inhibitor omeprazole (50-400 microM), and the vacuolar-type H(+)-ATPase inhibitor bafilomycin A1 (1-5 microM) only produced a dose-dependent acidification of the cells when used at high concentrations. In addition, steady-state pHi depended on the availability of cellular ATP, since it was decreased by the ATP synthase inhibitors oligomycin (1 microgram/ml) and sodium azide (1 mM), and by the uncoupler of oxidative phosphorylation carbonyl cyanide p-trifluorophenylhydrazone (1 microM), agents that were able to deplete significantly the intracellular ATP levels. Taken together, these results are consistent with an important role of an H(+)-ATPase similar to those found in other fungi in the regulation of pHi homoeostasis in P. carinii trophozoites.


Subject(s)
Cytoplasm/metabolism , Pneumocystis/enzymology , Proton-Translocating ATPases/metabolism , 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , Azides/pharmacology , Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology , Cell Line , Dicyclohexylcarbodiimide/pharmacology , Diethylstilbestrol/pharmacology , Enzyme Inhibitors/pharmacology , Ethylmaleimide/pharmacology , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Humans , Hydrogen-Ion Concentration , Ionophores/pharmacology , Lung/microbiology , Potassium/pharmacology , Proton-Translocating ATPases/antagonists & inhibitors , Sodium/pharmacology , Sodium Azide , Sulfhydryl Reagents/pharmacology
20.
J Eukaryot Microbiol ; 41(3): 223-8, 1994.
Article in English | MEDLINE | ID: mdl-8049685

ABSTRACT

The degree of strain and/or species diversity among Pneumocystis carinii isolates is unknown. As a first approach to the study of P. carinii genetic relatedness, we compared the pulsed field gel electrophoretic karyotypes of P. carinii derived from lung homogenates of three immunosuppressed host animals: rats transtracheally inoculated with P. carinii-infected mouse lung; and ferrets which developed reactivated latent P. carinii pneumonia. Rat P. carinii propagated on HEL299 cells was also examined. Karyotypes of P. carinii DNA from both rat lung homogenate and cell culture were identical (14 bands, 315-680 kb). In contrast, mouse and ferret P. carinii DNA karyotypes were each distinctly different from the rat P. carinii samples (mouse P. carinii 15 bands, 315-610 kb; ferret P. carinii nine bands, 410-760 kb). Three distinct rat P. carinii gene probes reacted with both Southern-transferred rat and mouse P. carinii DNA but not with ferret P. carinii DNA. Thus, P. carinii from rat, mouse, and ferret are genetically diverse. The results are consistent with recently reported antigenic and nucleic acid sequence differences among P. carinii isolates recovered from different hosts.


Subject(s)
Genes, Fungal , Genetic Variation , Pneumocystis/genetics , Animals , Blotting, Southern , Cell Line , DNA, Fungal/analysis , Electrophoresis, Gel, Pulsed-Field , Ferrets , Immunosuppression Therapy , Karyotyping , Lung/microbiology , Mice , Mice, Inbred BALB C , Pneumonia, Pneumocystis/microbiology , Pneumonia, Pneumocystis/veterinary , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...